Rate My Professor Braeden Donaldson

Donaldson's research interests focus on the development of immunotherapeutic vaccines as novel cancer therapies, utilizing rabbit haemorrhagic disease virus (RHDV) virus-like particles (VLP) as a scaffold for chemical conjugation and recombinant insertion of tumour-associated antigens. These vaccines have induced potent anti-tumour immune responses in murine models of melanoma, lung cancer, and colorectal cancer, with ongoing work to adapt the platform for prostate cancer and breast cancer toward human clinical trials. His teaching commitments encompass pathology, medical laboratory science, medicine, and various health sciences courses, including serving as Paper Convener for MELS208 Introduction to Diagnostic Pathology. In recognition of his teaching excellence, Donaldson received the Medical Laboratory Science Teaching Award from the Otago Medical School - Dunedin Campus in 2020. Key publications include "Virus-like particle vaccines: immunology and formulation for clinical translation" (2018), "Multi-target chimaeric VLP as a therapeutic vaccine in a model of colorectal cancer" (2017), "Virus-Like Particles, a Versatile Subunit Vaccine Platform" (2015), and "Delivering Two Tumour Antigens Survivin and Mucin-1 on Virus-Like Particles Enhances the Anti-Tumour Immune Response" (2021).